In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Chiron and Searle collaborate on coagulation inhibitor

Executive Summary

Chiron Corp. and Monsanto's GD Searle will collaborate on the development, manufacturing and marketing of tissue factor pathway inhibitor (TFPI), a naturally occurring soluble protein that inhibits blood coagulation.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Product or Technology Swap
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register